JPC
CELG

Jackson Park Capital’s Celgene Corp CELG Stock Holding History

Jackson Park Capital’s Portfolio CELG Stock Details CELG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		$1.27M Sell
11,000
-1,000
-8% -$111K 2.37% 20
2016
Q3 		$1.25M Hold
12,000
– – 1.63% 31
2016
Q2 		$1.18M Buy
+12,000
New +$1.24M 1.62% 28

Other funds holding CELG

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Jackson Park Capital's CELG Position: Q4 2016 in Review

Jackson Park Capital reduced its Celgene Corp (CELG) stake by 8.3% in Q4 2016, selling an estimated $111K and leaving 11,000 shares worth $1.27M. The position accounts for 2.37% of the portfolio, ranked #20.

Jackson Park Capital first reported a position in CELG in Q2 2016 and has held it in 3 quarters since. 1,375 funds tracked by Wall St. Rank hold CELG as of Q4 2016.

  • Jackson Park Capital held 11,000 shares of Celgene Corp worth $1.27M as of Q4 2016.
  • Jackson Park Capital sold 1,000 Celgene Corp shares in Q4 2016, an estimated $111K.
  • Celgene Corp made up 2.37% of Jackson Park Capital's portfolio in Q4 2016, its #20 holding.
  • Jackson Park Capital first reported a position in Celgene Corp in Q2 2016 and has held it in 3 quarters since.
  • 1,375 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2016.

Based on Jackson Park Capital's 13F filing for Q4 2016, filed 1 Feb 2017.